Out of 1 150, the Global Startup Heat Map highlights 5 Top Medical BioTech Startups
Startups such as the examples highlighted in this report focus on omic technologies, in-vitro solutions, tissue reconstruction, and drug development. While all of these technologies play a significant role in advancing biotechnology, they only represent the tip of the iceberg. This time, you get to discover five hand-picked medical biotech startups.
The Global Startup Heat Map below reveals the geographical distribution of 1 150 exemplary startups & scaleups we analyzed for this research. Further, it highlights five biotech startups that we hand-picked based on scouting criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these five startups & scaleups in this report. For insights on the other 1 145 medical biotech solutions, get in touch with us.
Aksense manufactures Point of Care (POC) Testing Kits
Founding Year: 2017
Location: London, UK
Funding: 250 000
Collaborate with Aksense for Portable Medical Diagnostics
UK-based startup Aksense develops portable diagnostic systems to detect infectious diseases. The POC devices use a diagnostic biosensor that enables rapid blood testing. It allows any person suffering from healthcare-associated infections to quickly receive a diagnosis without requiring complex and expensive laboratory testing. Moreover, this solution significantly reduces the time to identify diseases, thereby reducing the blockage of hospital beds due to long lab processing times.
TaiLai Biosciences advances Multi-omics Liquid Biopsy
Founding Year: 2018
Location: Shanghai, China
Work with TaiLai Bioscience for Cancer Treatment
Chinese startup TaiLai Biosciences specializes in cancer research using multi-omics technology. The startup’s product, Meta-Pan, uses patented pan-tumor screening technology for the accurate detection of over 14 common tumors simultaneously. Additionally, its screening technology utilizes a patented biomaterial that requires only 8ml of blood to analyze and detect traces of the tumors. This provides the medical industry with a non-invasive and rapid method to detect cancer at its early stages.
River BioMedics makes In-Vitro 3D Human Heart Tissue
Founding Year: 2020
Location: Enschede, Netherlands
Funding: USD 1,3 M
Reach out to River BioMedics for Cardiac Drug Development
Dutch startup River Biomedics focuses on bio-engineering and human-induced pluripotent stem cells (hiPSC) to develop cardiac drugs. The startup’s solution includes a 3D cardiac strip and heart-on-a-chip that uses hiPSC-cardiomyocytes to measure contraction, relaxation, and contractile kinetics. Besides, its assay, Mini-Heart, features a customizable heart shape, cell type, and disease phenotype. The assay also enables compound validation, compound screening, lead selection, and disease modeling. These solutions enable novel therapies for cardiac diseases by directly targeting the heart muscle.
Volumina Medical develops 3D Scaffolds
Founding Year: 2018
Location: Epalinges, Switzerland
Funding: 513 000
Partner with Volumina Medical for Tissue Reconstruction
Swiss startup Volumina Medical develops a minimally invasive solution to reconstruct soft tissue volumes. The startup’s platform of biomaterials for regenerative medicine, AdiPearl, is injectable in a safe and minimally invasive procedure. Moreover, the biomaterial feels like natural soft tissue and is shapable upon injection. The startup’s scaffolds are injectable through thin cannulas, reducing intervention and recovery time as well as enabling patients to solve the problem of natural repair of 3D soft tissues.
Gertrude Biomedical provides Small Molecule Inhibitors
Founding Year: 2019
Location: Melbourne, Australia
Innovate with Gertrude Biomedical for Cancer Genomics
Australian startup Gertrude Biomedical specializes in the control of abnormal vascular growth by targeting key gene switches. The startup’s solution targets a transcription factor in the cell nucleus called SOX18 that regulates gene pathways to manipulate the hallmarks of cancer. This targeted treatment breaks apart the SOX18 complex to modulate multiple downstream pathways and cellular functions. As a result, the solution finds applications in treating a wide range of medical conditions such as solid tumors, lung disease, and more.
Where is this Data from & how to Discover more BioTech Startups?
Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the BioTech industry. The insights of this data-driven analysis are derived from our Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & lets you scout relevant startups within a specific field in just a few clicks. To explore BioTech technologies in more detail, let us look into your areas of interest. For a more general overview, download our free BioTech Innovation Report to save your time and improve strategic decision-making.
